InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,578.00
(
-2.12%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.63
(
0.24%
)
Bitcoin
64,355.22
(
1.33%
)
Post# of 30
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Anthropoid

Send PM Follow Ignore
Followers 6
Posts 766
Boards Moderated 2
Alias Born 12/06/2013

Anthropoid

Member Level

Re: None

Thursday, 05/24/2018 2:15:01 PM

Thursday, May 24, 2018 2:15:01 PM

Post# of 30
A 2018 Orphan Drug Report shows continuing unmet medical need is set to fuel the growth of the worldwide orphan drug market with sales predicted to grow at over 11% a year to $262bn by 2024.

By 2024, orphan drugs will represent over a fifth of the worldwide prescription market.

Despite a slowdown in pricing, the report shows that the mean cost per patient per year still managed to hit $147,308 in 2017, more than four times the mean cost for non-orphan drugs at $30,708.

http://info.evaluategroup.com/OD2018-LP.html

be not idiot

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up